July/August 2013

Biopharma Asia

July/August 2013 | Volume 2 Issue 4


Catalent’s expansion into China

An interview with John Chiminski and Scott Houlton


Increasing flexibility in vaccine manufacturing processes and facilities with single-use d...

By: Tony D’Amore, Vice President, Bioprocess R&D; Yan-ping Yang, Director of Dow...


Beyond URS – MES vendor selection

By: Christian Hoferer, Senior Solution Architect F. Hoffmann-La Roche Ltd


The Value of Excipient GMP Certification

By: Irwin Silverstein, Vice President and Chief Operating Officer IPEA


Selected topics in moving from Gel Clot to Kinetic BET Testing

By: Kevin Williams, Research Scientist Hospira Inc


The coming of age of Heart in a Dish

By: Ashish Mehta, Senior Research Scientist; Chrishan Ramachandra, Research Fellow; W...


Using Next Generation Sequencing to understand Stem Cell biology

By: Vivek Tanavde, Principal Investigator Bioinformatics Institute, A*STAR


Differential Scanning Calorimetry (DSC) for Biopharmaceutical Development: Old concepts, ...

By: Sorina Morar-Mitrica, Scientific Investigator; Doug Nesta, Director, Biopharmaceut...


How to leverage technologies for the discovery of new Vaccines

By: Andrew Natenshon, Head China Research Strategy and Operations Novartis Vaccines &...


Combating pharmaceutical counterfeiting and diversion

By: Mark Davison , CEO Blue Sphere Health Ltd